NXN and neoplasm: The group of CS patients with TRG1–3 tumours (‘responders’) had a significantly longer OS than the group with TRG4–5 tumours (‘non‐responders) (HR = 1.53, 95% CI = 1.05–2.24, P = 0.026, Figures 2 and 3).